financetom
Business
financetom
/
Business
/
SunPower files for bankruptcy, to sell some $45 mln assets via stalking horse bid
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
SunPower files for bankruptcy, to sell some $45 mln assets via stalking horse bid
Aug 5, 2024 8:58 PM

Aug 5 (Reuters) - Solar firm SunPower said on

Monday it filed for Chapter 11 bankruptcy in the United States

and entered into a 'stalking horse' agreement with Complete

Solaria ( CSLR ) to sell some of its business for $45 million in

cash.

A stalking horse bid is used as a starting or minimally

accepted offer that other interested bidders must surpass if

they want to buy the asset or the company.

California-based Complete Solaria ( CSLR ), a solar technology,

services, and installation company will acquire SunPower's Blue

Raven Solar business, New Homes business, and non-installing

Dealer network.

SunPower had acquired Blue Raven for $165 million in 2021.

The company listed its assets and liabilities in the range

of $1 billion to $10 billion, in a filing with the bankruptcy

court in Delaware, court papers filed on Monday showed.

Additionally, SunPower said it intends to continue a sale

process for its remaining assets. The California-headquartered

company said that following the sale process it plans to

liquidate any remaining assets and undergo an efficient wind

down of its operations.

Earlier this year, SunPower said it planned to reduce its

workforce by about 1,000 people and planned to wind down its

SunPower Residential Installation locations and close SunPower

Direct sales.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
New Providence Acquisition Scraps Plan to Find Merger Partner, Will Wind Down Operations 'As Soon As Practicable'
New Providence Acquisition Scraps Plan to Find Merger Partner, Will Wind Down Operations 'As Soon As Practicable'
Nov 9, 2024
04:51 PM EST, 11/08/2024 (MT Newswires) -- New Providence Acquisition Corp. II ( NPAB ) shares were halted in Friday's late session after the blank check company said it plans to soon wind down operations and return its remaining equity to shareholders rather than complete a merger with a suitable business partner over the next year. New Providence shareholders last...
Radius Recycling Appoints Marc Hathhorn as COO
Radius Recycling Appoints Marc Hathhorn as COO
Nov 9, 2024
04:55 PM EST, 11/08/2024 (MT Newswires) -- Radius Recycling ( RDUS ) said Friday it appointed Marc Hathhorn as chief operating officer, starting Nov. 1. Hathhorn most recently served as president of global operations at Peabody Energy ( BTU ) , according to Radius. ...
Carrier Global Insider Sold Shares Worth $12,281,698, According to a Recent SEC Filing
Carrier Global Insider Sold Shares Worth $12,281,698, According to a Recent SEC Filing
Nov 9, 2024
04:58 PM EST, 11/08/2024 (MT Newswires) -- Kevin J. O'Connor, Senior Vice President & Chief Legal Officer, on November 06, 2024, sold 167,183 shares in Carrier Global ( CARR ) for $12,281,698. Following the Form 4 filing with the SEC, O'Connor has control over a total of 46,083 shares of the company, with 46,083 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1783180/000122520824009822/xslF345X05/doc4.xml...
Autolus Therapeutics' Leukemia Treatment Receives US FDA Approval
Autolus Therapeutics' Leukemia Treatment Receives US FDA Approval
Nov 9, 2024
04:58 PM EST, 11/08/2024 (MT Newswires) -- Autolus Therapeutics ( AUTL ) said late Friday its Aucatzyl programmed T cell therapy has received marketing authorization from the US Food and Drug Administration for the treatment of adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia. The safety of Aucatzyl includes a boxed warning for cytokine release syndrome, neurologic...
Copyright 2023-2026 - www.financetom.com All Rights Reserved